SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives

Sintx Technologies, Inc. (SINT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives SALT LAKE CITY, Utah – August 11, 2026 – SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a

Event · Guidance
Metric
total revenue
Period
third quarter of 2026
New
$900,000 to $1.1 million
Direction
initiate
Also in this documentContract · $3.2MOffering · $5M

Facts are quoted from the filing text and checked against it. Details that could not be matched to the text are left out.

Original reporting
Published Aug 11, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 8:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$SINT
Neutral
low confidence
Mentioned
$SINT
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SINTNeutralLow
01

Why it matters

The filing signals that SINT’s quarterly results and revenue outlook were updated and that commercialization and customer purchase order information was included in the furnished press release. However, the provided excerpt does not include the actual numbers or outlook range, limiting directional inference.

02

Market read

This is a routine but time-sensitive quarterly disclosure package. The tradable edge depends on the specific financial and outlook details inside Exhibit 99.1, which are not present in the scraped excerpt.

03

What to watch

Traders should verify Exhibit 99.1 for the specific revenue outlook, commercialization/customer order updates, and any risk factors or changes in assumptions that could shift valuation.

Relevance 7/10Novelty 3/10Timing: Filed Aug 11, 2026 after-hours, tied to the 10-Q for quarter ended June 30, 2026.

Background

The company filed an SEC Form 8-K (Item 2.02 and Item 7.01) on Aug 11, 2026, furnishing a press release as Exhibit 99.1 alongside its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026.

Company-level read

Ticker impact

$SINTNeutralLow confidence
Context

SINT filed an 8-K with Item 2.02 and furnished a press release updating results for the quarter ended June 30, 2026 and revenue outlook.

Expected impact

Near-term volatility is possible around the 10-Q/press-release details, but direction cannot be inferred from the provided excerpt.

Evidence & confidence

The 8-K confirms a business update and revenue outlook were issued, yet the excerpt contains no quantitative results, outlook ranges, or material changes that would drive a directional trading thesis.

Market effects

No sector-level implications are disclosed in the provided excerpt beyond routine quarterly update language.

None stated.

None stated.

Counterpoint

Because the excerpt omits the actual results and outlook figures, the market reaction may be driven by details not captured here, so trading based solely on this text could be misleading.

Key entities

  • SINTX Technologies, Inc.

    Subject of the 8-K, which furnished Exhibit 99.1 with results of operations, financial condition, and revenue outlook updates.

  • SEC Form 8-K

    Current report used to disclose results of operations and Regulation FD information via a furnished press release.

  • Exhibit 99.1

    Press release dated Aug 11, 2026 containing the business update and revenue outlook referenced by the 8-K.

Related articles

$SINTMed

SINTX Reports Record Third Quarter 2026 Revenue Growth and Advances Medical Device Commercialization

Sintx Technologies, Inc. (SINT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SINTX Reports Record Third Quarter 2026 Revenue Growth and Advances Medical Device Commercialization Third quarter revenue increases more than tenfold year over year, while operating losses decrease 51% as Company advances commercialization of its proprietary silicon

$SINTMed

SINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance

Sintx Technologies, Inc. (SINT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance Third-quarter revenue grows roughly 380% from Q2, driven by stronger-than-expected industrial sales to Fortune 500 customers; Company reiterates Q4 revenue guidance Revenue milestone

$SINTLow

Sintx Technologies (NASDAQ:SINT) Given “Buy” Rating at Maxim Group

Maxim Group reiterated a “Buy” rating on Sintx Technologies (NASDAQ:SINT) and set a $6.00 price target, implying 169.66% upside from the prior close, according to Benzinga. Other firms cited include Ascendiant (cut target to $12, Buy), Weiss (sell), and HC Wainwright (Buy, $10). SINT last traded at $2.23. The company reported Q EPS of ($0.70) vs ($0.66) consensus and revenue of $0.38M vs $0.30M.

$ZTEKFMed

Zentek Ltd. (ZTEKF): Financial results for FY2027

Zentek Ltd. (ZTEKF) furnished an SEC Form 6-K — earnings release. Zentek Q2 Fiscal 2027 Results News Release Zentek Strengthens Its Balance Sheet, Ends Second Quarter with $13.6 Million in Cash Working capital of $11.3 million at September 30, 2026, compared with a deficit of $1.3 million at March 31, 2026 Guelph, Ontario, November 16, 2026. Ze

$WBMedAI 8/10

Alibaba Is Pulling Back From This 10% Dividend Stock

Weibo (WB) missed Q3 revenue and earnings expectations, with advertising revenue from Alibaba (BABA) falling 33%. Shares dropped 4% premarket. GAAP net income fell 88.91%, operating cash flow turned negative, and long-term loans were reclassified as current. The dividend yield is 10.6%, but earnings are declining. CEO Gaofei Wang highlighted AI efforts, but ad budgets remain a concern.